title: Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients.
abstract: OBJECTIVE
  To determine short and longterm outcomes and prognostic factors for patients with systemic rheumatic diseases admitted to intensive care units in 4 teaching hospitals.
  
  
  METHODS
  All adult intensive care unit admissions over a 12 year period for systemic rheumatic diseases were retrospectively assessed. One hundred and eighty-one patients with a mean age of 57 +/- 17 years were studied.
  
  
  RESULTS
  The death rate in intensive care units was 33% (59/181) and in-hospital mortality was 43% (77/181). One hundred and four patients were discharged alive from hospital; 40 died during followup (mean 105 +/- 7 mo). The estimated 5 year survival rate for the discharged patients was 69%. The 4 factors significantly associated with in-hospital mortality by multivariate analysis were simplified acute physiologic score (p = 10(-4)), poor prior health status (p = 10(-4)), corticosteroid administration (p = 0.005), and the reason for admission; mortality was higher in the group admitted to intensive care for infectious complication (55 versus 34% for others; p = 0.006). In contrast, in-hospital mortality was not influenced by age or by systemic rheumatic diseases. Using Cox's model, only age over 60 years was a prognostic factor significantly associated with an increase in longterm mortality (p = 10(-4)).
  
  
  CONCLUSIONS
  The short term outcome for patients with systemic rheumatic diseases in intensive care units was poor. The longterm prognosis after hospital discharge appeared fair, although the standardized mortality ratio was 5-fold that of a nonselected population. Short and longterm prognoses were similar for different systemic rheumatic disease groups.
authors.affiliation: Service de Médecine Interne, Hôpital Henri Mondor, Créteil, France.
authors.forename: B
authors.initials: B
authors.lastname: Godeau
authors.forename: E
authors.initials: E
authors.lastname: Mortier
authors.forename: P M
authors.initials: PM
authors.lastname: Roy
authors.forename: S
authors.initials: S
authors.lastname: Chevret
authors.forename: G
authors.initials: G
authors.lastname: Bouachour
authors.forename: B
authors.initials: B
authors.lastname: Schlemmer
authors.forename: J
authors.initials: J
authors.lastname: Carlet
authors.forename: J F
authors.initials: JF
authors.lastname: Dhainaut
authors.forename: C
authors.initials: C
authors.lastname: Chastang
mesh_terms: D000328:Adult; D000368:Aged; D003240:Connective Tissue Diseases / Q000150:complications; D019115:Fasciitis, Necrotizing / Q000150:complications; D005260:Female; D006784:Hospitals, Teaching / Q000706:statistics & numerical data; D006801:Humans; D007362:Intensive Care Units / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D011379:Prognosis; D012189:Retrospective Studies; D012216:Rheumatic Diseases / Q000150:complications / Q000401:mortality* / Q000628:therapy; D012595:Scleroderma, Systemic / Q000150:complications; D016019:Survival Analysis; D013997:Time Factors